Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Federal Trade Commission
Accenture
Covington
Medtronic
Julphar

Generated: September 17, 2019

DrugPatentWatch Database Preview

Patent: 8,889,661

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,889,661
Title:Treatment of lupus nephritis using laquinimod
Abstract: This invention provides a method of treating a subject afflicted with active lupus nephritis comprising periodically administering to the subject an amount of laquinimod or pharmaceutically acceptable salt thereof effective to treat the subject. This invention also provides laquinimod or pharmaceutically acceptable salt thereof for use in treating a subject afflicted with active lupus nephritis. This invention further provides a pharmaceutical composition comprising an amount of laquinimod or pharmaceutically acceptable salt thereof for use in treating a subject afflicted with active lupus nephritis.
Inventor(s): Haviv; Asi (Kvutsat Shiller, IL), Tarcic; Nora (Modiin, IL)
Assignee: Teva Pharmaceutical Industries, Ltd. (Petach-Tikva, IL)
Application Number:13/039,178
Patent Claims:see list of patent claims

Details for Patent 8,889,661

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Sign Up Teva Pharmaceutical Industries, Ltd. (Petach-Tikva, IL) 2030-03-03 RX search
Bristol Myers Squibb ORENCIA abatacept INJECTABLE; IV (INFUSION) 125118 001 2005-12-23 ➤ Sign Up Teva Pharmaceutical Industries, Ltd. (Petach-Tikva, IL) 2030-03-03 RX search
Human Genome Sciences Inc. BENLYSTA belimumab INJECTABLE; INJECTION 125370 001 2011-03-09 ➤ Sign Up Teva Pharmaceutical Industries, Ltd. (Petach-Tikva, IL) 2030-03-03 RX search
Human Genome Sciences Inc. BENLYSTA belimumab INJECTABLE; INJECTION 125370 002 2011-03-09 ➤ Sign Up Teva Pharmaceutical Industries, Ltd. (Petach-Tikva, IL) 2030-03-03 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Deloitte
Chinese Patent Office
Federal Trade Commission
Queensland Health
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.